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This article aims to highlight the importance of
diagnosing serious soft tissue infections and insti-
gating treatment rapidly.
Introduction
Synergistic gangrene is an uncommon soft tissue
infection classically occurring at surgical sites.
Primary cases are rare but a high index of suspi-
cion is paramount in treating the disease success-
fully. We present the ﬁrst case of primary
synergistic gangrene affecting the breast which
was successfully managed through a combination
of resuscitation, parenteral antibiotics and surgery.
It is reasonable to suggest that such cases may
increase in incidence and all physicians treating
soft tissue infections must be aware of this poten-
tially fatal pathology.
Case presentation
A 39-year-old woman with a history of type 2 dia-
betes, deep vein thrombosis, gastritis, schizo-
phrenia and self-harm presented to the medical
admissions unit with a one-week history of a
right sub-mammary abscess followed by spread-
ing cellulitis of the breast. On examination she
was septic with a pyrexia of 39.2, blood pressure
of 127/65 and tachycardia of 110. Examination of
the breast revealed widespread cellulitis involving
the nipple and sub-mammary area spreading
to the axilla. Initial blood tests showed a white cell
count of 23.8 (neutrophils 19.9) and CRP of 428.
Simple cellulitis was diagnosed by the admitting
physicians and she was commenced on parenteral
antibiotics and ﬂuid resuscitation. Her condition
worsened despite intravenous benzyl penicillin
and ﬂucloxacillin. A surgical opinion was sought
on day three when she had evidence of synergistic
gangrene. The cellulitis had now spread and there
were areas of growing necrotic ulceration
(Figure 1). Resuscitation was commenced and
antibiotic therapy was adjusted to imipenem and
clindamycin based on local necrotizing fasciitis
guidelines. She was taken to theatre within a few
hours where a partial mastectomy was performed
and the wound was left open and packed
(Figure 2). Postoperatively she remained stable
on intensive care. The following day she returned
to theatre for further debridement.
The wound was monitored closely and a
vacuum dressing was applied to aid healing.
Signs of sepsis improved and she returned to the
ward on the ﬁfth postoperative day. Nutritional
supplements and adequate hydration were contin-
ued during her recovery. Secondary closure was
performed on day 13 after the initial operation
and there was no further breakdown or compro-
mise of the remaining tissues.
Preoperative cultures taken from the ulcers
identiﬁed a mixture of gram positive and negative
bacteria including Bacteroides spp (sensitive to
metronidazole, clindamycin and imipenem).
Histology conﬁrmed widespread microscopic
changes and abscess formation consistent with
gangrene. There was no evidence of malignancy.
Blood markers of infection progressively
improved and there were no signs of secondary
organ failure during her recovery.
She was discharged 22 days after her initial
admission. Intravenous antibiotics were adminis-
tered for a total of 10 days after the ﬁrst debride-
ment which were changed to an extended period
of oral antibiotics up until her discharge (co amox-
iclav and metronidazole). Follow-up has been
arranged where the possibility of reconstruction
will be considered.
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1Discussion
Synergistic gangrene is a rare but potentially fatal
polymicrobial soft tissue infection involving
organisms creating synergistic virulence.
1,2 It is
considered a separate entity to necrotizing fasciitis
and the course is often more insidious. Inoculation
occurs from a surgical incision or drain site and
conditions affecting the immune response are
risk factors, especially diabetes and obesity.
3–5
Synergistic gangrene is mostly seen at surgical
sites such as the abdomen or back
6,7 but cases
involving the peri-anal region and vulva with no
proceeding trauma have been reported.
3–5 It is
characterized by spreading cellulitis followed by
the formation of central ulcerated areas covered
with eschar and necrosis which grow relentlessly
unless treated.
8 By this time the patient will be
toxic with extensive tissue loss having already
occurred. There are few reports of synergistic
gangrene beyond surgical wounds with no docu-
mented cases of the breast as a primary site. A
single case of synergistic gangrene with secondary
involvement of the breast has been described
among a series in the literature.
5 Mastectomy
was performed but the patient subsequently
died due to septicaemia and uncontrolled
diabetes.
Despite there being considerable discrepancy
in the agreed diagnostic criteria, the literature is
unanimous in the requirement for prompt, aggres-
sive antibiotic therapy and early, radical surgical
intervention.
3,7–9 Given these patients may
present to a range of non-surgical specialties,
early assessment and referral is of vital impor-
tance. Outlined below is our management strategy
for this case which will serve as a guide for other
clinicians treating synergistic gangrene.
• Resuscitation and supportive treatment: Large
volumes of ﬂuid can become sequestered in
tissues and surface appearance may under rep-
resent that of underlying tissue damage. Fluid
replacement should be guided by local policy.
Postoperative complications are likely in these
patients including multi-organ dysfunction,
myocardial infarction, thrombosis and second-
ary sources of infection.
3–5 Adequate steps are
required to prevent these in addition to
meeting nutritional needs to allow an appropri-
ate immune response and adequate wound
healing. Hyperbaric wound oxygenation has
also been reported as an adjunct, but its efﬁcacy
is uncertain;
5,7,9
• Broad spectrum antibiotics: The ideal choice of
antibiotics is difﬁcult to ascertain due to signiﬁ-
cant bacterial heterogeneity and low frequency
of this condition. Most follow necrotizing fascii-
tis guidelines with reasonable effect.
3–5,9 Micro-
biologists should be involved early. Our
regime involved intravenous imipenem
500 mg QDS and clindamycin 600 mg QDS for
10 days followed by co amoxiclav 625 mg
QDS and metronidazole 500 mg TDS orally
for a further two weeks;
Figure 1
Preoperative and postoperative images of the
right breast. Note the presence of the ulcerative
necrotic areas which had rapidly appeared.
Radical debridement was performed to eliminate
all the diseased tissue and further debridement
was performed the following day
Figure 2
After initial debridement. Extensive removal of
diseased tissue was performed and is necessary
to control the spread of infection. Secondary
closure was subsequently performed on day 13
after her initial procedure
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2• Surgical debridement: The infection can spread
quickly causing marked local tissue destruc-
tion. Radical and often multiple surgical debri-
dements may be required to remove all the
diseased tissue.
3 Secondary closure should
only be attempted once tissues are viable and
nutritional and physiological state allows.
Operative samples should be sent for histologi-
cal and microbiological analysis.
It is reasonable to expect more cases of synergistic
gangrene due to the increase in immunosuppres-
sive conditions. This outline will help guide the
professionals these patients may present to and
highlightsthe importance of prompt identiﬁcation
and surgical intervention. The prognosis of syner-
gistic gangrene however, remains poor.
9 Despite
aggressive treatment, there is often a delay in diag-
nosis by which time patients are systemically
unwell. Mortality rates have been reported of
12.5% in those debrided within 24 h, in contrast
to 72.7% delayed by four days.
5
This report describes an unusual case of
primary synergistic gangrene affecting the breast
and explains our strategy for successful treatment
which shows that with punctual diagnosis and
appropriate intervention that fatality is not
inevitable.
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